|
1
|
Palazzo C, Nguyen C, Lefevre-Colau MM,
Rannou F and Poiraudeau S: Risk factors and burden of
osteoarthritis. Ann Phys Rehabil Med. 59:134–138. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Prieto-Alhambra D, Judge A, Javaid MK,
Cooper C, Diez-Perez A and Arden NK: Incidence and risk factors for
clinically diagnosed knee, hip and hand osteoarthritis: Influences
of age, gender and osteoarthritis affecting other joints. Ann Rheum
Dis. 73:1659–1664. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lohmander LS and Roos EM: Clinical update:
Treating osteoarthritis. Lancet. 370:2082–2084. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Loeser RF, Goldring SR, Scanzello CR and
Goldring MB: Osteoarthritis: A disease of the joint as an organ.
Arthritis Rheum. 64:1697–1707. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang M, Mani SB, He Y, Hall AM, Xu L, Li
Y, Zurakowski D, Jay GD and Warman ML: Induced superficial
chondrocyte death reduces catabolic cartilage damage in murine
posttraumatic osteoarthritis. J Clin Invest. 126:2893–2902. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou Q, Sun Y, Zhang P and Zheng J:
Simultaneously blocking necrosis and apoptosis to protect TMJ
chondrocytes from TNF-alpha induced death: A preliminary study. Int
J Clin Experiment Med. 9:2202–2210. 2016.
|
|
7
|
Jang KW, Buckwalter JA and Martin JA:
Inhibition of cell-matrix adhesions prevents cartilage chondrocyte
death following impact injury. J Orthop Res. 32:448–454. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Intekhab-Alam NY, White OB, Getting SJ,
Petsa A, Knight RA, Chowdrey HS, Townsend PA, Lawrence KM and Locke
IC: Urocortin protects chondrocytes from NO-induced apoptosis: A
future therapy for osteoarthritis? Cell Death Dis. 4:e7172013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Niu J, Clancy M, Aliabadi P, Vasan R and
Felson DT: Metabolic syndrome, its components, and knee
osteoarthritis: The framingham Osteoarthritis study. Arthritis
Rheumatol. 69:1194–1203. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Haugen IK, Ramachandran VS, Misra D, Neogi
T, Niu J, Yang T, Zhang Y and Felson DT: Hand osteoarthritis in
relation to mortality and incidence of cardiovascular disease: Data
from the Framingham Heart Study. Ann Rheum Dis. 74:74–81. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hussain S Monira, Wang Y, Cicuttini FM,
Simpson JA, Giles GG, Graves S and Wluka AE: Incidence of total
knee and hip replacement for osteoarthritis in relation to the
metabolic syndrome and its components: A prospective cohort study.
Semin Arthritis Rheum. 43:429–436. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bellamy N, Buchanan WW, Goldsmith CH,
Campbell J and Stitt LW: Validation study of WOMAC: A health status
instrument for measuring clinically important patient relevant
outcomes to antirheumatic drug therapy in patients with
osteoarthritis of the hip or knee. J Rheumatol. 15:1833–1840.
1988.PubMed/NCBI
|
|
13
|
Roorda LD, Jones CA, Waltz M, Lankhorst
GJ, Bouter LM, Van der Eijken JW, Willems WJ, Heyligers IC,
Voaklander DC, Kelly KD and Suarez-Almazor ME: Satisfactory cross
cultural equivalence of the Dutch WOMAC in patients with hip
osteoarthritis waiting for arthroplasty. Ann Rheum Dis. 63:36–42.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ji Y, Strawn TL, Grunz EA, Stevenson MJ,
Lohman AW, Lawrence DA and Fay WP: Multifaceted role of plasminogen
activator inhibitor-1 in regulating early remodeling of vein bypass
grafts. Arterioscler Thromb Vasc Biol. 31:1781–1787. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Goldring MB and Otero M: Inflammation in
osteoarthritis. Curr Opin Rheumatol. 23:471–478. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Almonte-Becerril M, Navarro-Garcia F,
Gonzalez-Robles A, Vega-Lopez MA, Lavalle C and Kouri JB: Cell
death of chondrocytes is a combination between apoptosis and
autophagy during the pathogenesis of Osteoarthritis within an
experimental model. Apoptosis. 15:631–638. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Balci B: The modification of serum lipids
after acute coronary syndrome and importance in clinical practice.
Curr Cardiol Rev. 7:272–276. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Libby P and Hansson GK: Inflammation and
immunity in diseases of the arterial tree: Players and layers. Circ
Res. 116:307–311. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Perrins CJ and Bobryshev YV: Current
advances in understanding of immunopathology of atherosclerosis.
Virchows Archiv. 458:117–123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Twardowski L, Cheng F, Michaelsen J,
Winter S, Hofmann U, Schaeffeler E, Müller S, Sonnenberg M, Steuer
K, Ott G, et al: Enzymatically modified low-density lipoprotein is
present in all stages of aortic valve sclerosis: Implications for
pathogenesis of the disease. J Am Heart Assoc. 4:e0021562015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sawamura T, Kume N, Aoyama T, Moriwaki H,
Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T and Masaki
T: An endothelial receptor for oxidized low-density lipoprotein.
Nature. 386:73–77. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu S, Ogura S, Chen J, Little PJ, Moss J
and Liu P: LOX-1 in atherosclerosis: Biological functions and
pharmacological modifiers. Cell Mol Life Sci. 70:2859–2872. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Misaka T, Suzuki S, Sakamoto N, Yamaki T,
Sugimoto K, Kunii H, Nakazato K, Saitoh S, Sawamura T, Ishibashi T
and Takeishi Y: Significance of soluble lectin-like oxidized LDL
receptor-1 levels in systemic and coronary circulation in acute
coronary syndrome. Biomed Res Int. 2014:6491852014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakagawa T, Akagi M, Hoshikawa H, Chen M,
Yasuda T, Mukai S, Ohsawa K, Masaki T, Nakamura T and Sawamura T:
Lectin-like oxidized low-density lipoprotein receptor 1 mediates
leukocyte infiltration and articular cartilage destruction in rat
zymosan-induced arthritis. Arthritis Rheum. 46:2486–2494. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nishimura S, Akagi M, Yoshida K, Hayakawa
S, Sawamura T, Munakata H and Hamanishi C: Oxidized low-density
lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor-1
(LOX-1) in cultured bovine articular chondrocytes increases
production of intracellular reactive oxygen species (ROS) resulting
in the activation of NF-kappaB. Osteoarthritis Cartilage.
12:568–576. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yumoto K, Nifuji A, Rittling SR, Tsuchiya
Y, Kon S, Uede T, Denhardt DT, Hemmi H, Notomi T, Hayata T, et al:
Osteopontin deficiency suppresses tumor necrosis factor-α-induced
apoptosis in chondrocytes. Cartilage. 3:79–85. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim J, Xu M, Xo R, Mates A, Wilson GL, AW
IV Pearsall and Grishko V: Mitochondrial DNA damage is involved in
apoptosis caused by pro-inflammatory cytokines in human OA
chondrocytes. Osteoarthritis Cartilage. 18:424–432. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Csaki C, Mobasheri A and Shakibaei M:
Synergistic chondroprotective effects of curcumin and resveratrol
in human articular chondrocytes: Inhibition of IL-1beta-induced
NF-kappaB-mediated inflammation and apoptosis. Arthritis Res Ther.
11:R1652009. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Caramés B, López-Armada MJ, Cillero-Pastor
B, Lires-Dean M, Vaamonde C, Galdo F and Blanco FJ: Differential
effects of tumor necrosis factor-alpha and interleukin-1beta on
cell death in human articular chondrocytes. Osteoarthritis
Cartilage. 16:715–722. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
López-Armada MJ, Caramés B, Lires-Deán M,
Cillero-Pastor B, Ruiz-Romero C, Galdo F and Blanco FJ: Cytokines,
tumor necrosis factor-alpha and interleukin-1beta, differentially
regulate apoptosis in osteoarthritis cultured human chondrocytes.
Osteoarthritis Cartilage. 14:660–669. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee SW, Song YS, Lee SY, Yoon YG, Lee SH,
Park BS, Yun I, Choi H, Kim K, Chung WT and Yoo YH: Downregulation
of protein kinase CK2 activity facilitates tumor necrosis
factor-α-mediated chondrocyte death through apoptosis and
autophagy. PLoS One. 6:e191632011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiang LB, Meng DH, Lee SM, Liu SH, Xu QT,
Wang Y and Zhang J: Dihydroartemisinin inhibits catabolism in rat
chondrocytes by activating autophagy via inhibition of the NF-κB
pathway. Sci Rep. 6:389792016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang K: Autophagy and apoptosis in liver
injury. Cell Cycle. 14:1631–1642. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jia J, Yao W, Guan M, Dai W, Shahnazari M,
Kar R, Bonewald L, Jiang JX and Lane NE: Glucocorticoid dose
determines osteocyte cell fate. FASEB J. 25:3366–3376. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mizushima N: Physiological functions of
autophagy. Curr Top Microbiol Immunol. 335:71–84. 2009.PubMed/NCBI
|
|
36
|
Shapiro IM, Layfield R, Lotz M, Settembre
C and Whitehouse C: Boning up on autophagy: The role of autophagy
in skeletal biology. Autophagy. 10:7–19. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sasaki H, Takayama K, Matsushita T, Ishida
K, Kubo S, Matsumoto T, Fujita N, Oka S, Kurosaka M and Kuroda R:
Autophagy modulates osteoarthritis-related gene expression in human
chondrocytes. Arthritis Rheum. 64:1920–1928. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hong D, Bai YP, Gao HC, Wang X, Li LF,
Zhang GG and Hu CP: Ox-LDL induces endothelial cell apoptosis via
the LOX-1-dependent endoplasmic reticulum stress pathway.
Atherosclerosis. 235:310–317. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zheng H, Cui D, Quan X, Yang W, Li Y,
Zhang L and Liu E: Lp-PLA2 silencing protects against
ox-LDL-induced oxidative stress and cell apoptosis via Akt/mTOR
signaling pathway in human THP1 macrophages. Biochem Biophys Res
Commun. 477:1017–1023. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Del Carlo M Jr and Loeser RF: Cell death
in osteoarthritis. Curr Rheumatol Rep. 10:37–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
D'Lima D, Hermida J, Hashimoto S, Colwell
C and Lotz M: Caspase inhibitors reduce severity of cartilage
lesions in experimental osteoarthritis. Arthritis Rheum.
54:1814–1821. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kuhn K, D'Lima DD, Hashimoto S and Lotz M:
Cell death in cartilage. Osteoarthritis Cartilage. 12:1–16. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mathew R and White E: Autophagy in
tumorigenesis and energy metabolism: Friend by day, foe by night.
Curr Opin Genet Dev. 21:113–119. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bhutia SK, Mukhopadhyay S, Sinha N, Das
DN, Panda PK, Patra SK, Maiti TK, Mandal M, Dent P, Wang XY, et al:
Autophagy: Cancer's friend or foe? Adv Cancer Res. 118:61–95. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Marx J: Autophagy: Is it cancer's friend
or foe? Science. 312:1160–1161. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lis K, Kuzawinska O and Bałkowiec-Iskra E:
Tumor necrosis factor inhibitors-state of knowledge. Arch Med Sci.
10:1175–1185. 2014. View Article : Google Scholar : PubMed/NCBI
|
